An in vitro study showed that TMEM59 expression affects Golgi localised complex glycosylation, reducing galactosylation and sialylation of key AD related proteins such as APP, BACE1 and nicastrin using western blot analysis. Here, BACE1 is linked to Alzheimer disease.